Most hereditary ataxias do not currently have a definitive cure that reverses the underlying genetic change and completely restores normal neurological function. However, treatment options are available to manage symptoms, address complications, preserve independence and improve quality of life. Importantly, some inherited ataxias have specific treatments that can slow or prevent further neurological damage.

One example is ataxia with vitamin E deficiency (AVED), caused by pathogenic variants in the TTPA gene. These variants interfere with vitamin E transport and can lead to progressive neurological symptoms. Vitamin E supplementation under medical supervision can prevent progression and may improve some symptoms, particularly when treatment starts early. This makes early diagnosis particularly important.

Friedreich ataxia is another inherited neurological disorder. Omaveloxolone is an approved treatment for eligible patients in certain countries, including the United States. Clinical trials have shown benefits in neurological function measures, although the medication is not a cure and does not eliminate the underlying genetic variant. Approval, availability and eligibility vary by country, age and clinical circumstances.

For many spinocerebellar ataxias, treatment focuses on symptom management and rehabilitation. Physiotherapy can help maintain balance, strength and mobility. Occupational therapy can support everyday activities, while speech and language therapy may help with communication and swallowing difficulties. Assistive devices, such as walking aids, can reduce falls and improve independence.

Doctors may also monitor for associated complications, including muscle stiffness, neuropathy, vision problems, swallowing difficulties and heart disease where relevant. Genetic counselling helps patients and families understand the diagnosis, inheritance pattern and reproductive implications.

Research into hereditary ataxia is progressing. Investigational approaches include gene-based therapies, RNA-targeted treatments and other strategies intended to modify disease mechanisms. However, experimental therapies should not be considered established cures unless supported by appropriate evidence and regulatory approval.

Treatment plans should be tailored to the specific genetic condition, symptoms and individual health needs. Patients should avoid taking high-dose vitamins or other supplements without medical advice, as unnecessary supplementation can cause harm.